GPT-5 Solves 3-Year Immunology Mystery, Advancing Cancer Research
GPT-5 Pro helped immunologist Derya Unutmaz solve a three-year-old puzzle about how T cells behave, specifically regarding an unusual subset of T cells. This breakthrough could accelerate research into cancer and autoimmune diseases.

OpenAI's GPT-5 Pro helped immunologist Derya Unutmaz crack a three-year-old mystery about an unusual subset of T cells that baffled researchers. T cells are white blood cells crucial for the immune system. Unutmaz had long wondered why certain T cells seemed to shut down in response to stimuli that normally activate them. GPT-5 Pro analyzed complex data, including cell RNA sequences, and identified that these T cells were not defective but instead specialized — they had a built-in safety mechanism to prevent overactive immune responses.
This discovery matters because it could lead to better treatments for cancer and autoimmune diseases. Understanding how these 'regulatory-like' T cells work might allow researchers to design therapies that selectively suppress harmful immune attacks in autoimmune conditions, or enhance immune activity against tumors. Think of it like finding a hidden key that could unlock new ways to fight illnesses.